Futuremeds

Wroclaw 53-673

0 studies enrolling now · 5 studies all time

What they study most

Crohn's Disease, Dyslipidemias, Hyperlipidemias, Hyperlipoproteinemias, Hypertension, Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease, Primary Sjogrens Disease

Studies at this site

• A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome — Running, not enrolling
• Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension — Completed
• Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH) — Completed
• Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease — Completed
• A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70) — Completed